improvement in IBS severity vs. control. 69% of participants reported clinically meaningful relief.
Placebos can help even when you know.
Five evidence-based protocols that harness your brain's own pharmacy to improve your condition.
Designed using research from the world's leading institutions
The founding study
2010
A groundbreaking Harvard study showed that an honest placebo could actually help patients.[1]
This incredible trial showed that IBS patients who received honest placebos reported clinically meaningful relief almost twice as frequently vs control. This kicked off an entirely new field of research into honest placebos, called Open Label Placebos (OLPs) and has been cited more than 1250 times in other publications.
[1] Kaptchuk T.J. et al. (2010). “Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome.” PLoS ONE 5(12):e15591. View study →
Gold-standard science
Gold-standard science has confirmed the positive effect of honest placebos across conditions.
Analog × Digital
But not everyone can participate in a research study at Harvard.
Copables creates science-backed 14 day protocols that use placebos and cognitive restructuring to replicate participation in the research studies from home.
How over what
The science shows that how you take something can matter just as much as what you are taking.
Inside-out
Your brain has its own pharmacy. It just needs to be unlocked.
Studies have shown that non-deceptive placebos can cause your brain to produce the very same symptom-relieving chemicals present in real pharmacology.
See the Science →
A new field
Placebos are one of the most underutilized tools in modern medicine.
Open Label Placebos are an emerging field of research whose benefits lie locked away in research labs. Until now.
View 272 OLP publications in PubMed →Copables is an anagram of the word “placebos.”
Our protocols
Learn more about our Protocols
reduction in negative emotions vs. control. Brain scans confirmed activation of emotion-regulation circuitry.
reduction in PMS symptoms in a 2025 RCT.
reduction in anxiety-induced test failure. Driving-test failure dropped from 53% to 29%.
improvement in fatigue severity in cancer survivors. 39% improvement in fatigue-disrupted quality of life.
Start Free Assessment →